Copyright Reports & Markets. All rights reserved.

Global Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Monoclonal Antibodies
    • 1.2.3 Therapeutic Proteins
    • 1.2.4 Vaccines
  • 1.3 Market by Application
    • 1.3.1 Global Biologic Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Clinical Medicine
    • 1.3.3 Laboratory
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Biologic Therapeutic Drug Market Perspective (2016-2027)
  • 2.2 Biologic Therapeutic Drug Growth Trends by Regions
    • 2.2.1 Biologic Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Biologic Therapeutic Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Biologic Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Biologic Therapeutic Drug Industry Dynamic
    • 2.3.1 Biologic Therapeutic Drug Market Trends
    • 2.3.2 Biologic Therapeutic Drug Market Drivers
    • 2.3.3 Biologic Therapeutic Drug Market Challenges
    • 2.3.4 Biologic Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Biologic Therapeutic Drug Players by Revenue
    • 3.1.1 Global Top Biologic Therapeutic Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Biologic Therapeutic Drug Revenue
  • 3.4 Global Biologic Therapeutic Drug Market Concentration Ratio
    • 3.4.1 Global Biologic Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutic Drug Revenue in 2020
  • 3.5 Biologic Therapeutic Drug Key Players Head office and Area Served
  • 3.6 Key Players Biologic Therapeutic Drug Product Solution and Service
  • 3.7 Date of Enter into Biologic Therapeutic Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Biologic Therapeutic Drug Breakdown Data by Type

  • 4.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Biologic Therapeutic Drug Breakdown Data by Application

  • 5.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Biologic Therapeutic Drug Market Size (2016-2027)
  • 6.2 North America Biologic Therapeutic Drug Market Size by Type
    • 6.2.1 North America Biologic Therapeutic Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Biologic Therapeutic Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Biologic Therapeutic Drug Market Size by Type (2016-2027)
  • 6.3 North America Biologic Therapeutic Drug Market Size by Application
    • 6.3.1 North America Biologic Therapeutic Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Biologic Therapeutic Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Biologic Therapeutic Drug Market Size by Application (2016-2027)
  • 6.4 North America Biologic Therapeutic Drug Market Size by Country
    • 6.4.1 North America Biologic Therapeutic Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Biologic Therapeutic Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Biologic Therapeutic Drug Market Size (2016-2027)
  • 7.2 Europe Biologic Therapeutic Drug Market Size by Type
    • 7.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Biologic Therapeutic Drug Market Size by Type (2016-2027)
  • 7.3 Europe Biologic Therapeutic Drug Market Size by Application
    • 7.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Biologic Therapeutic Drug Market Size by Application (2016-2027)
  • 7.4 Europe Biologic Therapeutic Drug Market Size by Country
    • 7.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Biologic Therapeutic Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type
    • 8.2.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application
    • 8.3.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Biologic Therapeutic Drug Market Size by Region
    • 8.4.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Biologic Therapeutic Drug Market Size (2016-2027)
  • 9.2 Latin America Biologic Therapeutic Drug Market Size by Type
    • 9.2.1 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Biologic Therapeutic Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Biologic Therapeutic Drug Market Size by Application
    • 9.3.1 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Biologic Therapeutic Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Biologic Therapeutic Drug Market Size by Country
    • 9.4.1 Latin America Biologic Therapeutic Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Biologic Therapeutic Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Biologic Therapeutic Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type
    • 10.2.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application
    • 10.3.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Biologic Therapeutic Drug Market Size by Country
    • 10.4.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Aurobindo Pharma Ltd.
    • 11.1.1 Aurobindo Pharma Ltd. Company Details
    • 11.1.2 Aurobindo Pharma Ltd. Business Overview
    • 11.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Introduction
    • 11.1.4 Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.1.5 Aurobindo Pharma Ltd. Recent Development
  • 11.2 Concord Biotech
    • 11.2.1 Concord Biotech Company Details
    • 11.2.2 Concord Biotech Business Overview
    • 11.2.3 Concord Biotech Biologic Therapeutic Drug Introduction
    • 11.2.4 Concord Biotech Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.2.5 Concord Biotech Recent Development
  • 11.3 GlaxoSmithKline Plc.
    • 11.3.1 GlaxoSmithKline Plc. Company Details
    • 11.3.2 GlaxoSmithKline Plc. Business Overview
    • 11.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Introduction
    • 11.3.4 GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.3.5 GlaxoSmithKline Plc. Recent Development
  • 11.4 H. Lundbeck A/S
    • 11.4.1 H. Lundbeck A/S Company Details
    • 11.4.2 H. Lundbeck A/S Business Overview
    • 11.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Introduction
    • 11.4.4 H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.4.5 H. Lundbeck A/S Recent Development
  • 11.5 Novartis Global
    • 11.5.1 Novartis Global Company Details
    • 11.5.2 Novartis Global Business Overview
    • 11.5.3 Novartis Global Biologic Therapeutic Drug Introduction
    • 11.5.4 Novartis Global Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.5.5 Novartis Global Recent Development
  • 11.6 Retractable Technologies, Inc.
    • 11.6.1 Retractable Technologies, Inc. Company Details
    • 11.6.2 Retractable Technologies, Inc. Business Overview
    • 11.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Introduction
    • 11.6.4 Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.6.5 Retractable Technologies, Inc. Recent Development
  • 11.7 Smith Medical
    • 11.7.1 Smith Medical Company Details
    • 11.7.2 Smith Medical Business Overview
    • 11.7.3 Smith Medical Biologic Therapeutic Drug Introduction
    • 11.7.4 Smith Medical Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.7.5 Smith Medical Recent Development
  • 11.8 AstraZeneca
    • 11.8.1 AstraZeneca Company Details
    • 11.8.2 AstraZeneca Business Overview
    • 11.8.3 AstraZeneca Biologic Therapeutic Drug Introduction
    • 11.8.4 AstraZeneca Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.8.5 AstraZeneca Recent Development
  • 11.9 Pfizer Inc.
    • 11.9.1 Pfizer Inc. Company Details
    • 11.9.2 Pfizer Inc. Business Overview
    • 11.9.3 Pfizer Inc. Biologic Therapeutic Drug Introduction
    • 11.9.4 Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.9.5 Pfizer Inc. Recent Development
  • 11.10 Merck and Co. Inc.
    • 11.10.1 Merck and Co. Inc. Company Details
    • 11.10.2 Merck and Co. Inc. Business Overview
    • 11.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Introduction
    • 11.10.4 Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
    • 11.10.5 Merck and Co. Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Biologic Therapeutic Drug Scope and Market Size
    Biologic Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Monoclonal Antibodies
    Therapeutic Proteins
    Vaccines

    Segment by Application
    Clinical Medicine
    Laboratory
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Aurobindo Pharma Ltd.
    Concord Biotech
    GlaxoSmithKline Plc.
    H. Lundbeck A/S
    Novartis Global
    Retractable Technologies, Inc.
    Smith Medical
    AstraZeneca
    Pfizer Inc.
    Merck and Co. Inc.

    Buy now